BridgeMD
New treatment option for Anal Cancer
Official title Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure Prophylaxis
ClinicalTrials.gov ID: NCT07029152
What this study is testing
- What it's testing
- This study aims to learn more about anal cancer risk in men who have sex with men (MSM) who are using Pre-Exposure Prophylaxis (PrEP) to prevent HIV. Specifically, we want to check how common High-Grade Squamous Intraepithelial Lesions (HSIL) are in this group, how well anal swabs can screen for these lesions, and how having HSIL affects their quality of life.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 35 and older, men only
You may be able to join if
- HIV-uninfected MSM (men who have sex with men) aged 35 years or older.
- participants must have been using PrEP for at least 3 months.
- Dutch, English or French speaking and writing
You likely can't join if
- Any intervention in the (peri-)anal region within the past 3 months
- Enema usage within 2 h before sampling
- Currently undergoing peri-anal topical HPV-treatment
- HRA in the last year (anal swab or HRA prior to the last year is no exclusion)
The study team makes the final eligibility decision.
Where it's taking place
- Bruges, Belgium
- Brussels, Belgium
- Ghent, Belgium
- Hasselt, Belgium
- Leuven, Belgium
- Lodelinsart, Belgium
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 35 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bruges, Belgium; Brussels, Belgium; Ghent, Belgium; Hasselt, Belgium; Leuven, Belgium; Lodelinsart, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.